Phase 2 Cervical Cancers Clinical Trials
8 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–8 of 8 trials
Recruiting
Phase 2
Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).
Cervical Cancers
Stanford University41 enrolled1 locationNCT07022470
Recruiting
Phase 1Phase 2
Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
Ovarian CancerPancreatic CarcinomaAdvanced Solid Tumors+1 more
Evopoint Biosciences Inc.350 enrolled24 locationsNCT06799637
Recruiting
Phase 2
Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors
Cervical Cancers
Tianjin Medical University Cancer Institute and Hospital134 enrolled1 locationNCT06727617
Recruiting
Phase 2
Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC
LOCALLY ADVANCED CERVICAL CANCERS
Cancer Institute and Hospital, Chinese Academy of Medical Sciences30 enrolled1 locationNCT07232654
Recruiting
Phase 2
Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 and IIA1 Cervical Cancer
Cervical Cancers
Obstetrics & Gynecology Hospital of Fudan University20 enrolled1 locationNCT07130240
Recruiting
Phase 1Phase 2
A Beta-only IL-2 ImmunoTherapY Study
Triple-Negative Breast CancerEsophageal CancerGastric Cancer+34 more
Medicenna Therapeutics, Inc.115 enrolled27 locationsNCT05086692
Recruiting
Phase 2
Neoadjuvant Immunochemotherapy for Locally Advanced Cervical Cancer: a Prospective, Single-arm, Phase II Clinical Trial
Cervical Cancers
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University34 enrolled1 locationNCT07003620
Recruiting
Phase 2
Iparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC
Cervical Cancers
Obstetrics & Gynecology Hospital of Fudan University35 enrolled1 locationNCT06878222